Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...
Marc Davis | June 25, 2021 |

Bioasis Technologies: A Very BIG Year in Review

It’s been a very busy, big and ambitious year for Bioasis Technologies Inc. ( TSX-V.BTI , OTC:BIOAF , Forum ) – a biopharmaceutical company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and...
Dave Jackson | December 17, 2020 |

Have the Stock Bulls Really Sealed the Short-Term Crack in the Dam?

Stocks again made a new intraday 2020 high yesterday, but the bulls were stopped just a point shy of the 3395 mark. Has yesterday’s increase invalidated our reasons to be cautious and take profits off the table? In other words, can we expect the bulls to push t...
Monica Kingsley | February 20, 2020 |

Hemostemix Founder: A Man with a Compassionate Heart

The Canadian stem cell company Hemostemix Inc. ( TSX-V: HEM , OTC: HMTXF ) was founded by a man who truly had a compassionate heart and a clear intent to establish a breakthrough in heart disease using the same technology that saved his life. Roger Bergersen, who train...
Featured Submission | December 14, 2020 |

Is Gold’s Apparent Resilience a Show of Its True Strength?

Some things change, and some things don’t. On the precious metals market and the related ones, we currently have both. There are trends that were unaffected by last week’s developments, but there are certain markets that made powerful moves and ...
Przemyslaw Radomski, CFA | March 25, 2019 |

Treasure Hunting in Fondaway Canyon Nevada

Getchell Gold Corp. ( CSE: GTCH , OTCQB: GGLDF ) a leading Nevada focused Gold and Copper exploration company was interviewed in the inaugural edition of the Canadian Securities Exchange's "Mining Mondays" program. Host, Barrington Miller interviewed Mike Sieb who is a ...
Featured Submission | July 6, 2020 |

The promise of AI

In ‘The Terminator’ series of action films starring Arnold Schwarzenegger, a cybernetic organism (cyborg) is programmed from the future to go back in time and kill the mother of the scientist who leads the fight against Skynet, an artificial intelligence syst...
Richard (Rick) Mills | November 22, 2019 |

A ‘Barrier’ to Better Health

(Click image to play podcast) The blood-brain barrier plays an essential role in protecting the brain from blood-borne disease. But is also one of medicine’s great paradoxes – a system designed to protect the most sensitive region of the body bu...
Dave Jackson | September 29, 2020 |

Crystal Lake Mining In The News

Crystal Lake Mining Corporation ( TSXV: CLM; OTC: SIOCF; FSE: SOG-FF) (”Crystal Lake” or the “ Company ”) has reported some interesting forward-motion developments lately, including the inclusion of two...
Dr. Kal Kotecha | June 20, 2019 |

I do not trust the markets currently but Cole Evans is a different story.

These are perilous times with both a fast spreading virus and socioeconomic challenges. This was the theme of my talk at the newsletter writers presentation at PDAC and during my media interviews. Markets have a propensity to overshoot and over correct. Unfortunately I was r...
Dr. Kal Kotecha | March 9, 2020 |
1 2 3 4 5 6 7 8 9 10 ...